1399. Efficacy of Daptomycin Combination with β-Lactams for Daptomycin-resistant Enterococcus faecium Harboring LiaSR Substitutions

BACKGROUND: Daptomycin (DAP) is one of the mainstay treatments for Enterococcus faecium infections. However, development of resistance threatens its continued viability as a treatment option. Although the mechanisms of DAP resistance in enterococci are not fully comprehended, they are associated wit...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Open Forum Infect Dis
Autors principals: Kebriaei, Razieh, Rice, Seth, Singh, Kavindra, Stamper, Kyle, Dinh, An, Rios, Rafael, Diaz, Lorena, Murray, Barbara, Munita, Jose M, Tran, Truc T, Arias, Cesar, Rybak, Michael J
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2018
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6252901/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.1230
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars